Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-023025
Filing Date
2020-11-06
Accepted
2020-11-06 17:00:56
Documents
5
Effectiveness Date
2020-11-06

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A cbli20201103_defa14a.htm DEFA14A 23551
2 n01.jpg GRAPHIC 131154
3 n02.jpg GRAPHIC 167421
4 n03.jpg GRAPHIC 57467
5 n04.jpg GRAPHIC 58725
  Complete submission text file 0001437749-20-023025.txt   596083
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32954 | Film No.: 201295192
SIC: 8731 Services-Commercial Physical & Biological Research